Company / R&D Expense
IDEAYA Biosciences, Inc. R&D Expense History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$314.7M
FY2025
5-year range
$34.3M / $314.7M
FY2021-FY2025
Trend
+6.8%
vs FY2024
Sector context
#58 of 210
Health Care
What the data says
At $315M, IDEAYA Biosciences, Inc.'s r&d expense ranks #58 of 210 in the Health Care sector. R&D Expense has increased for 5 consecutive years, from $32M in FY2020 to $315M in FY2025.
Based on SEC 10-K filings.
$315M in FY2025 with a 5-year CAGR of +58.2%.
Improved from $130M to $315M over the past 2 years.
Health Care sector context is included.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +99.4%
- 5-Year CAGR
- +58.2%
- 10-Year CAGR
- -
Sector benchmark
#58 of 210 in Health CareTop 28% of 210This company $314.7M Sector average $644.0M
▼
-51.1% below sector average
Key checks
Key Insights
- IDEAYA Biosciences, Inc.'s r&d expense has grown for 5 consecutive years.
- 5-year CAGR of +58.2%, indicating consistent growth.
- In FY2025, r&d expense increased 6.8% year-over-year.
- Ranks #58 out of 210 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 4.55 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $314.7M | +6.8% |
| FY2024 | $294.7M | +127.5% |
| FY2023 | $129.5M | +226.2% |
| FY2022 | $39.7M | +15.7% |
| FY2021 | $34.3M | +8.1% |
| FY2020 | $31.7M | -7.5% |
| FY2019 | $34.3M | +8.1% |
| FY2018 | $31.7M | +156.4% |
| FY2017 | $12.4M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026